<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Module 08: Isotopes, Shielding & Special Topics</title>
<style>
:root {
--primary: #2c3e50;
--accent: #8e44ad;
--highlight: #f1c40f;
--bg-light: #fdfefe;
--white: #ffffff;
}
body { font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif; line-height:1.6; color:var(--primary); max-width:900px; margin:0 auto; padding:20px; background-color:var(--bg-light); }
h1 { text-align:center; color:var(--primary); border-bottom:3px solid var(--accent); padding-bottom:15px; margin-bottom:40px; }
.module-header { background: linear-gradient(90deg, var(--accent), var(--primary)); color: var(--white); padding: 15px 20px; border-radius: 8px; margin-top: 50px; display:flex; align-items:center;}
.module-number { background:var(--white); color:var(--accent); width:30px; height:30px; border-radius:50%; display:inline-flex; align-items:center; justify-content:center; font-weight:bold; margin-right:15px; }
.concept-block { background:var(--white); border-radius:8px; padding:25px; margin:20px 0; box-shadow:0 4px 6px rgba(0,0,0,0.05); border-left:5px solid var(--accent); }
table { width:100%; border-collapse:collapse; margin-top:15px; }
th { background-color:var(--accent); color:white; padding:10px; text-align:left; }
td { border:1px solid #ddd; padding:10px; }
.watch-out { background-color:#fff8e1; border:1px solid #ffe0b2; border-radius:5px; padding:15px; margin-top:15px; font-size:0.9em; }
</style>
</head>
<body>
<h1>Module 08: Isotopes, Shielding & Special Topics</h1>
<p style="text-align:center; font-size:1.1em;">Brachytherapy Isotopes, Barrier Calculation Factors, and Pharmacology.</p>

<div class="module-header"><span class="module-number">1</span><h2>Radioactive Isotopes (Brachytherapy)</h2></div>
<div class="concept-block">
<h3>1.1 Common Clinical Isotopes</h3>
<table>
<tr><th>Isotope</th><th>Half-Life (T½)</th><th>Common Use</th></tr>
<tr><td><strong>Cobalt-60</strong></td><td>5.26 years</td><td>External Beam (Gamma Knife), HDR.</td></tr>
<tr><td><strong>Cesium-137</strong></td><td>30 years</td><td>LDR GYN (Tandem & Ovoids).</td></tr>
<tr><td><strong>Iridium-192</strong></td><td>74 days</td><td>HDR sources.</td></tr>
<tr><td><strong>Iodine-125</strong></td><td>60 days</td><td>Permanent Prostate Seeds (LDR).</td></tr>
<tr><td><strong>Palladium-103</strong></td><td>17 days</td><td>Permanent Prostate Seeds.</td></tr>
<tr><td><strong>Gold-198</strong></td><td>2.7 days</td><td>Permanent Implants (historical).</td></tr>
</table>
<div class="watch-out"><strong>Formula:</strong> Activity = Initial × (0.5)^(time / T½)</div>
</div>

<div class="module-header"><span class="module-number">2</span><h2>Shielding Calculation Factors</h2></div>
<div class="concept-block">
<p><strong>Barrier variables:</strong> W (workload), U (use factor), T (occupancy)</p>
<table>
<tr><th>Factor</th><th>Name</th><th>Definition</th></tr>
<tr><td>W</td><td>Workload</td><td>How much the machine is on (cGy/week)</td></tr>
<tr><td>U</td><td>Use Factor</td><td>Fraction of beam time pointed at a specific wall</td></tr>
<tr><td>T</td><td>Occupancy Factor</td><td>Who is on the other side (office vs corridor)</td></tr>
</table>
</div>

<div class="module-header"><span class="module-number">3</span><h2>Chemotherapy & Pharmacology</h2></div>
<div class="concept-block">
<p><strong>Radiosensitizers vs Radioprotectors</strong></p>
<table>
<tr><th>Class</th><th>Drug</th><th>Effect</th></tr>
<tr><td>Radiosensitizer</td><td>Doxorubicin</td><td>Increases tumor radiosensitivity (cardiotoxic risk)</td></tr>
<tr><td>Radioprotector</td><td>Amifostine</td><td>Protects normal tissues (salivary glands)</td></tr>
</table>
<div class="watch-out"><strong>Toxicities:</strong> Bleomycin → lung; Doxorubicin → heart; Vincristine → neuro; Cisplatin → kidney/hearing</div>
</div>

</body>
</html>